Evidence map›Paper›PMID 38860011›Full record

ArticleOxford medical case reports2024

Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease.

Kathryn Biddle, Elif Agaoglu, Geoffrey Brent, John Adam, Rachel Nockels, Adam Loveridge, Farid Bazari, Janakan Natkunarajah, Israa Al-Shakarchi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxford medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kathryn BiddleSt George's University of London, Infection and Immunity, Cranmer Terrace, London, SW17 0RE, UK.ORCID https://orcid.org/0000-0001-5267-200X
Elif AgaogluKingston Hospital NHS Foundation Trust, Respiratory, Kingston upon Thames, KT2 7QB, UK.
Geoffrey BrentKingston Hospital NHS Foundation Trust, Dermatology, Kingston upon Thames, KT2 7QB, UK.
John AdamKingston Hospital NHS Foundation Trust, General Medicine, Kingston upon Thames, KT2 7QB, UK.ORCID https://orcid.org/0000-0002-4247-2204
Rachel NockelsKingston Hospital NHS Foundation Trust, General Medicine, Kingston upon Thames, KT2 7QB, UK.
Adam LoveridgeKingston Hospital NHS Foundation Trust, Respiratory, Kingston upon Thames, KT2 7QB, UK.
Farid BazariKingston Hospital NHS Foundation Trust, Respiratory, Kingston upon Thames, KT2 7QB, UK.
Janakan NatkunarajahKingston Hospital NHS Foundation Trust, Dermatology, Kingston upon Thames, KT2 7QB, UK.
Israa Al-ShakarchiKingston Hospital NHS Foundation Trust, Rheumatology, Kingston upon Thames, KT2 7QB, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-MDA-5 dermatomyositis (DM) is a subtype of idiopathic inflammatory myopathy, commonly presenting as clinically amyopathic dermatomyositis. It is associated with rapidly progressive interstitial lung disease and a poor prognosis. Here, we present two cases of anti-MDA-5 DM and discuss the challenges associated with timely diagnosis, and the importance of early and aggressive treatment.

Indexed as

critical care medicinedermatologyimmunologyrespiratory disordersrheumatology

Identifiers

PMID38860011
PMCPMC11162590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.